Thousands of bottles of a prescription medicine for treating high blood pressure and congestive heart failure have been recalled over the detection of trace amounts of a possible carcinogen. About ...

Another pharmaceutical company has recalled its Losartan tablets because of the detection of a trace amount of a potential cancer-causing contaminant. Camber Pharmaceuticals, Inc. has recalled 87 lots ...

(CBS) -- Another blood pressure drug is being recalled after being found to contain trace amounts of a potentially cancer-causing ingredient, one of a slew of recalls of medications to treat ...

More blood pressure drugs are being recalled after being found to contain trace amounts of a potentially cancer-causing ingredient, one of a slew of recalls of medications to treat hypertension. Since ...

(CNN) — Thousands of bottles of blood-pressure medicine are being recalled. The drugmaker Camber Pharmaceuticals is pulling about 56,000 bottles of Losartan – which is used to treat high blood ...

Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Tuesday that Arbli (losartan potassium) Oral Suspension, 10 mg/mL, has been added to the formularies of key national payors, expanding access ...

The primary end point was the proportion of patients achieving goal mean trough SiDBP (<90 mm Hg) after 4 weeks of therapy with either losartan 50 mg/HCTZ 12.5 mg or a losartan monotherapy regimen ...

April 15, 2008 (Chicago, IL) - The new direct renin inhibitor aliskiren (Tekturna, Novartis), in combination with losartan (Cozaar, Merck) is no more effective than either drug alone for reducing left ...

Hypertension is a major risk factor for ischemic heart disease. 1 Furthermore, hypertension is also the most prevalent independent risk factor for atrial fibrillation (AF). 2 Therefore, ischemic heart ...